Full Press Release Details
Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference.
IRD
Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Key Takeaway: Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Price reaction · baseline $1.08 (2025-08-04 close) · hit after-hours · clean, no other IRD news in the window
day 0 close · peak
+2.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy